Metric Finance
LearnFAQ
LearnFAQ

Learn / SPRY

NASDAQ: SPRY

ARS Pharmaceuticals (SPRY) stock, explained like you're 5

ARS Pharmaceuticals trades on the Nasdaq under the ticker SPRY. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 421 million dollars.

Ticker
SPRY
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 421 million dollars

Is ARS Pharmaceuticals a small, medium or large cap company?

No. ARS Pharmaceuticals is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 421 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How ARS Pharmaceuticals makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves SPRY stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • SPRY, PASG, BOXL: Why These Stocks Plunged Double Digits In After Hours Trading Today (Stocktwits)
  • ARS Pharmaceuticals (NasdaqGM:SPRY) Stock Forecast & Analyst Predictions (Simply Wall Street)
  • SPRY Oct 2026 7.500 call (SPRY261016C00007500) interactive stock chart (Yahoo Finance UK)
  • ARS Pharmaceuticals' Needle Free Epinephrine Spray Posts $26.2M in Q2 Sales (Stock Titan)
  • SPRY Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in ARS Pharmaceuticals Inc. Securities Class Action Contact SueWallSt (PR Newswire)

Follow SPRY in your daily brief

Each trading day at 5 PM ET we post what happened to ARS Pharmaceuticals and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow SPRY

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about ARS Pharmaceuticals stock

What does ARS Pharmaceuticals do?

ARS Pharmaceuticals trades on the Nasdaq under the ticker SPRY. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 421 million dollars.

What is the ticker symbol for ARS Pharmaceuticals?

ARS Pharmaceuticals trades under the ticker SPRY on the Nasdaq.

What is ARS Pharmaceuticals's market cap?

ARS Pharmaceuticals is a small cap stock with a market cap of about 421 million dollars.

How does ARS Pharmaceuticals make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves SPRY stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow SPRY stock every day?

Add SPRY to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow SPRY daily

A free brief on ARS Pharmaceuticals and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare SPRY: SPRY vs NVS, SPRY vs AZN, SPRY vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed